Home LiteratureArticle Details
PMID: 12563012 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle.

The Journal of physiology ·Vol. 546 ·No. Pt 3 ·2003-02-01 ·Pages 879-89

Kitazawa T, Eto M, Woodsome TP, Khalequzzaman M

Abstract

Myosin phosphatase (MLCP) plays a critical regulatory role in the Ca(2+) sensitivity of myosin phosphorylation and smooth muscle contraction. It has been suggested that phosphorylation at Thr(695) of the MLCP regulatory subunit (MYPT1) and at Thr(38) of the MLCP inhibitor protein CPI-17 results in inhibition of MLCP activity. We have previously demonstrated that CPI-17 Thr(38) phosphorylation plays an important role in G-protein-mediated inhibition of MLCP in tonic arterial smooth muscle. Here, we attempted to evaluate the function of MYPT1 in phasic rabbit portal vein (PV) and vas deferens (VD) smooth muscles. Using site- and phospho-specific antibodies, phosphorylation of MYPT1 Thr(695) and CPI-17 Thr(38) was examined along with MYPT1 Thr(850), which is a non-inhibitory Rho-kinase site. We found that both CPI-17 Thr(38) and MYPT1 Thr(850) were phosphorylated in response to agonists or GTPgammaS concurrently with contraction and myosin phosphorylation in alpha-toxin-permeabilized PV tissues. In contrast, phosphorylation of MYPT1 Thr(695) did not increase. Comparable results were also obtained in both permeabilized and intact VD. The Rho-kinase inhibitor Y-27632 and the protein kinase C (PKC) inhibitor GF109203X suppressed phosphorylation of MYPT1 Thr(850) and CPI-17 Thr(38), respectively, in intact VD while MYPT1 Thr(695) phosphorylation was insensitive to both inhibitors. These results indicate that phosphorylation of MYPT1 Thr(695) is independent of stimulation of G-proteins, Rho-kinase or PKC. In the phasic PV, phosphorylation of CPI-17 Thr(38) may contribute towards inhibition of MLCP while the phasic visceral VD, which has a low CPI-17 concentration, probably utilizes other Ca(2+) sensitizing mechanisms for inhibiting MLCP besides phosphorylation of MYPT1 and CPI-17.

MeSH Terms
Amides/pharmacology Animals Calcium/metabolism Electrophysiology Endothelin-1/pharmacology Enzyme Inhibitors/pharmacology Indoles/pharmacology Isoenzymes/metabolism Male Maleimides/pharmacology Muscle Proteins/metabolism Muscle, Smooth/metabolism Muscle, Smooth, Vascular/physiology Myosin Light Chains/metabolism Myosin-Light-Chain Phosphatase Permeability Phenylephrine/pharmacology Phosphoprotein Phosphatases/metabolism Phosphoproteins/metabolism Phosphorylation Portal Vein/physiology Pyridines/pharmacology Rabbits Type C Phospholipases/pharmacology Vas Deferens/physiology Vasoconstriction
Chemicals
Amides CPI-17 protein, Oryctolagus cuniculus Endothelin-1 Enzyme Inhibitors Indoles Isoenzymes Maleimides Muscle Proteins Myosin Light Chains Phosphoproteins Pyridines Y 27632 Phenylephrine Phosphoprotein Phosphatases Myosin-Light-Chain Phosphatase Type C Phospholipases bisindolylmaleimide I Calcium
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Kitazawa Toshio
Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, DC 20007, USA. [email protected]
Eto Masumi
Woodsome Terence P
Khalequzzaman Md
References (44)
44 references, click to expand
  1. Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms.
    J Biol Chem. 2001 Aug 3;276(31):29072-8 PMID: 11397799
  2. Signal transduction and regulation in smooth muscle.
    Nature. 1994 Nov 17;372(6503):231-6 PMID: 7969467
  3. Expression of CPI-17 and myosin phosphatase correlates with Ca(2+) sensitivity of protein kinase C-induced contraction in rabbit smooth muscle.
    J Physiol. 2001 Sep 1;535(Pt 2):553-64 PMID: 11533144
  4. Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase.
    Biochem J. 2002 Jun 1;364(Pt 2):431-40 PMID: 12023886
  5. Integrin-linked kinase phosphorylates the myosin phosphatase target subunit at the inhibitory site in platelet cytoskeleton.
    Biochem J. 2002 Jul 1;365(Pt 1):79-87 PMID: 11931630
  6. Smooth muscle myosin phosphatase-associated kinase induces Ca2+ sensitization via myosin phosphatase inhibition.
    J Biol Chem. 2002 Jun 28;277(26):23441-6 PMID: 11976330
  7. Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase.
    Biochem J. 2002 Aug 15;366(Pt 1):211-6 PMID: 12030846
  8. Phosphorylation of the regulatory subunit of smooth muscle protein phosphatase 1M at Thr850 induces its dissociation from myosin.
    FEBS Lett. 2002 Sep 11;527(1-3):101-4 PMID: 12220642
  9. Regulation of smooth muscle contractile elements by second messengers.
    Annu Rev Physiol. 1989;51:299-313 PMID: 2653184
  10. G-protein-mediated Ca2+ sensitization of smooth muscle contraction through myosin light chain phosphorylation.
    J Biol Chem. 1991 Jan 25;266(3):1708-15 PMID: 1671041
  11. G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle.
    Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9307-10 PMID: 1656467
  12. GTP gamma S-dependent regulation of smooth muscle contractile elements.
    Am J Physiol. 1992 Feb;262(2 Pt 1):C405-10 PMID: 1311501
  13. Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction.
    J Biol Chem. 1992 May 5;267(13):8719-22 PMID: 1577714
  14. Rapid turnover of myosin light chain phosphate during cross-bridge cycling in smooth muscle.
    Am J Physiol. 1994 Oct;267(4 Pt 1):C1160-6 PMID: 7943280
  15. Molecular cloning of cDNA encoding the 110 kDa and 21 kDa regulatory subunits of smooth muscle protein phosphatase 1M.
    FEBS Lett. 1994 Dec 12;356(1):51-5 PMID: 7988720
  16. A novel mechanism for the Ca(2+)-sensitizing effect of protein kinase C on vascular smooth muscle: inhibition of myosin light chain phosphatase.
    J Gen Physiol. 1994 Aug;104(2):265-86 PMID: 7807049
  17. Thiophosphorylation of the 130-kDa subunit is associated with a decreased activity of myosin light chain phosphatase in alpha-toxin-permeabilized smooth muscle.
    J Biol Chem. 1995 Aug 4;270(31):18191-4 PMID: 7629133
  18. Cyclic GMP-dependent stimulation reverses G-protein-coupled inhibition of smooth muscle myosin light chain phosphate.
    Biochem Biophys Res Commun. 1996 Mar 27;220(3):658-63 PMID: 8607821
  19. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)
    Science. 1996 Jul 12;273(5272):245-8 PMID: 8662509
  20. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase).
    J Biol Chem. 1996 Aug 23;271(34):20246-9 PMID: 8702756
  21. Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase.
    J Biol Chem. 1999 Dec 24;274(52):37385-90 PMID: 10601309
  22. A novel phosphoprotein inhibitor of protein type-1 phosphatase holoenzymes.
    Biochemistry. 1999 Dec 21;38(51):16952-7 PMID: 10606530
  23. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II.
    J Physiol. 2000 Jan 15;522 Pt 2:177-85 PMID: 10639096
  24. Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells.
    Am J Physiol Cell Physiol. 2000 Jan;278(1):C57-65 PMID: 10644512
  25. Inhibition of Rho-associated kinase blocks agonist-induced Ca2+ sensitization of myosin phosphorylation and force in guinea-pig ileum.
    J Physiol. 2000 Jan 1;522 Pt 1:33-49 PMID: 10618150
  26. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility.
    J Biol Chem. 2000 Apr 7;275(14):9897-900 PMID: 10744661
  27. Inhibition of myosin/moesin phosphatase by expression of the phosphoinhibitor protein CPI-17 alters microfilament organization and retards cell spreading.
    Cell Motil Cytoskeleton. 2000 Jul;46(3):222-34 PMID: 10913968
  28. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells.
    Trends Pharmacol Sci. 2001 Jan;22(1):32-9 PMID: 11165670
  29. Identification of the endogenous smooth muscle myosin phosphatase-associated kinase.
    Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2419-24 PMID: 11226254
  30. Myotonic dystrophy protein kinase phosphorylates the myosin phosphatase targeting subunit and inhibits myosin phosphatase activity.
    FEBS Lett. 2001 Mar 30;493(2-3):80-4 PMID: 11287000
  31. Protein kinase C-catalyzed phosphorylation of an inhibitory phosphoprotein of myosin phosphatase is involved in human platelet secretion.
    Blood. 2001 Jun 15;97(12):3798-805 PMID: 11389019
  32. Invited review: regulation of myosin phosphorylation in smooth muscle.
    J Appl Physiol (1985). 2001 Jul;91(1):497-503 PMID: 11408468
  33. A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization.
    J Biochem. 1995 Dec;118(6):1104-7 PMID: 8720121
  34. Noradrenaline and ATP: cotransmitters and neuromodulators.
    J Physiol Pharmacol. 1995 Dec;46(4):365-84 PMID: 8770783
  35. Cyclic GMP causes Ca2+ desensitization in vascular smooth muscle by activating the myosin light chain phosphatase.
    J Biol Chem. 1997 Feb 21;272(8):5063-8 PMID: 9030570
  36. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation.
    J Biol Chem. 1997 May 9;272(19):12257-60 PMID: 9139666
  37. Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle.
    FEBS Lett. 1997 Jun 30;410(2-3):356-60 PMID: 9237662
  38. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension.
    Nature. 1997 Oct 30;389(6654):990-4 PMID: 9353125
  39. Possible involvement of the novel CPI-17 protein in protein kinase C signal transduction of rabbit arterial smooth muscle.
    J Physiol. 1998 May 1;508 ( Pt 3):871-81 PMID: 9518739
  40. Myosin light chain phosphatase: subunit composition, interactions and regulation.
    J Muscle Res Cell Motil. 1998 May;19(4):325-41 PMID: 9635276
  41. Rho-associated kinase of chicken gizzard smooth muscle.
    J Biol Chem. 1999 Feb 5;274(6):3744-52 PMID: 9920927
  42. Identification of trimeric myosin phosphatase (PP1M) as a target for a novel PKC-potentiated protein phosphatase-1 inhibitory protein (CPI17) in porcine aorta smooth muscle.
    J Biochem. 1999 Feb;125(2):354-62 PMID: 9990134
  43. Reconstitution of protein kinase C-induced contractile Ca2+ sensitization in triton X-100-demembranated rabbit arterial smooth muscle.
    J Physiol. 1999 Oct 1;520 Pt 1:139-52 PMID: 10517807
  44. Selected contribution: insulin utilizes NO/cGMP pathway to activate myosin phosphatase via Rho inhibition in vascular smooth muscle.
    J Appl Physiol (1985). 2001 Sep;91(3):1475-82 PMID: 11509551
Article Info
Journal
The Journal of physiology
Abbr.
J Physiol
ISSN
0022-3751
Published
2003-02-01
Pages
879-89
Language
English
Region
England
NLM ID
0266262
PMCID
PMC2342583
Subset
IM
Grants
NHLBI NIH HHS · R01 HL070881 · United States
NHLBI NIH HHS · HL70881 · United States
NHLBI NIH HHS · R01HL51824 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]